Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia

Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia

Ashish Kumar Gupta,1,* Ruchika Pokhriyal,1,* Mohd Imran Khan,1 Domada Ratna Kumar,1 Rishab Gupta,2 Rakesh Kumar Chadda,2 Rashmi Ramachandran,3 Vinay Goyal,4 Manjari Tripathi,4 Gururao Hariprasad1 1Department of Biophysics; 2Department of Psychiatry; 3Department of Anaesthesia; 4Department of Neurolo...

Full description

Bibliographic Details
Main Authors: Gupta AK, Pokhriyal R, Khan MI, Kumar DR, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G
Format: Article
Language:English
Published: Dove Medical Press 2019-10-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Parkinson's disease
Schizophrenia
iTRAQ proteomics
dopamine
biomarkers
therapeutic efficacy
alpha 2 macroglobulin
Online Access:https://www.dovepress.com/cerebrospinal-fluid-proteomics-for-identification-of-alpha2-macroglobu-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/cerebrospinal-fluid-proteomics-for-identification-of-alpha2-macroglobu-peer-reviewed-article-NDT

Similar Items